![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
UCLA's Dr. Antoni Ribas Discusses PD1 and PD-L1 Targeted Cancer Drugs (UCLA Jonsson Comprehensive Cancer Center) View |
![]() |
UCLA's Dr. Antoni Ribas discusses PD1 and PD-L1 targeted cancer drugs (BatteryPark.TV) View |
![]() |
UCLA's Dr. Garon Discusses PD1 and PD-L1 Drugs Treating Non-Small Cell Lung Cancer (UCLA Jonsson Comprehensive Cancer Center) View |
![]() |
Immunotherapy in Oncology and the Role of the PD-L1 Biomarker (AJMCtv MJH) View |
![]() |
PD-1 targeting immunotherapy MK-3475 has high, long-lasting activity against metastatic melanoma (ecancer) View |
![]() |
GRACEcast-113 Lung-Cancer ASCO 2012 LC Highlights: Dr. Neal on Anti-PD-1 Immunotherapy for NSCLC (GRACE - Global Resource for Advancing Cancer Education) View |
![]() |
Jonsson Comprehensive Cancer Center (UCLA Jonsson Comprehensive Cancer Center) View |
![]() |
Drug of the Year: PD1 (EJCancer) View |
![]() |
MK-3475 (Inhibitor of PD-1) and its Efficacy in Lung Cancer (Oncology.TV) View |
![]() |
2018 NAM Annual Meeting - Resistance to Immune Therapy (National Academy of Medicine) View |